Glioblastoma with PRMT5gene upregulation is a key target for tumor cell regression

MLA

Kurdi, Maher, et al. “Glioblastoma with PRMT5gene Upregulation Is a Key Target for Tumor Cell Regression.” Oncologie, vol. 26, no. 2, Feb. 2024, pp. 239–46. EBSCOhost, https://doi.org/10.1515/oncologie-2023-0534.

APA

Kurdi, M., Fadul, M. M., Addas, B., Faizo, E., Bamaga, A. K., Alsinani, T., Katib, Y., Alkhotani, A., Fathaddin, A. A., Turkistani, A. N., Najjar, A. A., Baeesa, S., Toonsi, F. A., Almansouri, M., & Alkhayyat, S. (2024). Glioblastoma with PRMT5gene upregulation is a key target for tumor cell regression. Oncologie, 26(2), 239–246. https://doi.org/10.1515/oncologie-2023-0534

Chicago

Kurdi, Maher, Motaz M. Fadul, Bassam Addas, Eyad Faizo, Ahmed K. Bamaga, Taghreed Alsinani, Yousef Katib, et al. 2024. “Glioblastoma with PRMT5gene Upregulation Is a Key Target for Tumor Cell Regression.” Oncologie 26 (2): 239–46. doi:10.1515/oncologie-2023-0534.